FHC
XENE icon

First Horizon Corporation’s Xenon Pharmaceuticals XENE Stock Holding History

First Horizon Corporation’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51K Buy
25
+1
+4% +$56 ﹤0.01% 1384
2026
Q1 		$1.4K Buy
+24
New +$1.11K ﹤0.01% 1319

Other funds holding XENE

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

First Horizon Corporation's XENE Position: Q2 2026 in Review

First Horizon Corporation increased its Xenon Pharmaceuticals (XENE) stake by 4.2% in Q2 2026, buying an estimated $56 and bringing the position to 25 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

First Horizon Corporation first reported a position in XENE in Q1 2026 and has held it in 2 quarters since. 52 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • First Horizon Corporation held 25 shares of Xenon Pharmaceuticals worth $1.51K as of Q2 2026.
  • First Horizon Corporation bought 1 Xenon Pharmaceuticals share in Q2 2026, an estimated $56.
  • Xenon Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1384 holding.
  • First Horizon Corporation first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 52 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.